Minerva Neurosciences

Minerva Neurosciences EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Minerva Neurosciences (NERV) as of Nov 5, 2026 is -0.02. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -19.84 — a change of -99.90% (higher).

EV/FCF

-0.02

YoY

-99.90%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Minerva Neurosciences is 2025 -0.02 . EV/FCF (Enterprise Value to Free Cash Flow) of Minerva Neurosciences was 2024 -19.84 . It decreases by -99.90% higher compared to the previous year.

The Minerva Neurosciences EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-6.23 USD
Jan 1, 2019
-6.98 USD
Jan 1, 2020
-9.57 USD
Jan 1, 2021
-11.72 USD
Jan 1, 2022
-12.70 USD
Jan 1, 2023
-26.40 USD
Jan 1, 2024
-19.84 USD
Jan 1, 2025
-0.02 USD
The Minerva Neurosciences EV/FCF history
YEAREV/FCFYoY
-0.02-99.90%
-19.84-24.85%
-26.40+107.93%
-12.70+8.36%
-11.72+22.43%
-9.57+37.02%
-6.98+12.15%
-6.23-108.41%
74.02-793.00%
-10.68-20.53%
-13.44+46.36%
-9.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Minerva Neurosciences Stock analysis

What does Minerva Neurosciences do? Minerva Neurosciences Inc, based in Waltham, US, is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system diseases. The company, listed in 2014, operates with a portfolio including MIN-101 for schizophrenia, MIN-202 for insomnia and depression, MIN-117 for depression, and MIN-301 for Parkinson's disease. It employs seven full-time staff and targets neurological conditions through innovative biotechnology approaches. Minerva Neurosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Minerva Neurosciences stock

EV/FCF (Enterprise Value to Free Cash Flow) of Minerva Neurosciences is -0.02 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Minerva Neurosciences changed from -19.84 to -0.02, representing a -99.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Minerva Neurosciences since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Minerva Neurosciences with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Minerva Neurosciences

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Minerva Neurosciences